Our study showed in two independent cohorts of breast tumors that a high nuclear expression of PRMT5 is associated with a prolonged survival of tamoxifen-treated patients….Nuclear PRMT5 is associated with patient survival and interacts with ERα...These results may have potential clinical application at diagnosis as a high nuclear PRMT5 expression constitutes a predictive biomarker of tamoxifen sensitivity for premenopausal women.